![Robert Sebastian Habib](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Sebastian Habib
Vorstandsvorsitzender bei MiNA Therapeutics Ltd.
Profil
Robert Sebastian Habib has held positions as CEO and Director at MiNA Therapeutics Ltd.
and Director at Mina (Holdings) Ltd.
Aktive Positionen von Robert Sebastian Habib
Unternehmen | Position | Beginn |
---|---|---|
Mina (Holdings) Ltd.
![]() Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is a holding company. The private company is based in London, UK and was founded in 2014. | Direktor/Vorstandsmitglied | 03.11.2014 |
MiNA Therapeutics Ltd.
![]() MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Mina (Holdings) Ltd.
![]() Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is a holding company. The private company is based in London, UK and was founded in 2014. | Finance |
MiNA Therapeutics Ltd.
![]() MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Health Technology |